Last legs: These Droitwich transmission towers are all that's keeping the RTS service going Two decades-old pieces of glass and metal are all that stands between 900,000 UK energy meters working properly or being severely disrupted, and even turned off. In the last few weeks and months, many energy firms have been contacting their Economy 7 and 10 customers to …
The World Health Organisation recommended the R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India for use as it met required safety, quality and effectiveness standards, according to a report by news agency ANI. The vaccine was recommended for use after a rigorous, detailed scientific review by the Strategic Advisory Group of Experts and …
The story so far: India added a record 10 Gigawatt of solar energy to its cumulative installed capacity in 2021. This is a milestone in India’s journey towards generating 500 GW from renewable energy by 2030, of which 300 GW is expected to come from solar power. India’s capacity additions rank the country fifth in solar power deployment, contributing nearly …
At a time when the world is contending with a hitherto unseen and unknown foe in the novel coronavirus, you might wonder why a vaccine for malaria is making news. The RTS,S/AS01 vaccine, which has the brand name Mosquirix, has been developed by the UK-based pharma major GSK to act against Plasmodium falciparum, “the deadliest malaria parasite globally and the …
Global pharma major GSK, non-profit health organisation PATH and Bharat Biotech have signed a product transfer agreement pertaining to malaria vaccine RTS,S/AS01. The agreement includes transfer of manufacturing of the RTS,S antigen part of the vaccine and grant of a licence on all rights pertaining to the RTS,S/AS01 malaria vaccine to Bharat Biotech. A joint release on Wednesday said GSK …